AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Bruce D. Cheson, John M. Bennett, Thomas Büchner et al. · Journal of Clinical Oncology · 2003 · 2.7K citations

Medicine, Hematology, Oncology +17

ISCN 1995 An international system for human cytogenetic nomenclature

Felix Mitelman · 1995 · 1.9K citations

Life Sciences, Biology, Genetics +10

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

H Miyoshi, K Shimizu, T Kozu et al. · Proceedings of the National Academy of Sciences · 1991 · 884 citations

Life Sciences, Genetics, Molecular Genetics +17

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

Susanne Schnittger, Tobias Kohl, Torsten Haferlach et al. · Blood · 2005 · 379 citations · Full text

Medicine, Genetics, Molecular Genetics +11

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

Roberto Cairoli · Blood · 2005 · 374 citations · Full text

Medicine, Hematology, Oncology +17